Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Update

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) was the target of a large decline in short interest in June. As of June 15th, there was short interest totaling 1,568 shares, a decline of 59.4% from the May 31st total of 3,862 shares. Based on an average daily trading volume, of 106,636 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.

Xtant Medical Trading Up 4.5%

NYSEAMERICAN XTNT opened at $0.44 on Wednesday. Xtant Medical has a fifty-two week low of $0.40 and a fifty-two week high of $0.95. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.64 and a current ratio of 3.34. The stock has a 50 day simple moving average of $0.48 and a two-hundred day simple moving average of $0.57. The stock has a market cap of $61.71 million, a P/E ratio of 44.04 and a beta of -0.16.

Xtant Medical (NYSEAMERICAN:XTNT) last announced its earnings results on Wednesday, May 13th. The medical device company reported ($0.02) EPS for the quarter, meeting analysts’ consensus estimates of ($0.02). Xtant Medical had a net margin of 1.50% and a return on equity of 3.68%. The firm had revenue of $20.88 million for the quarter, compared to analysts’ expectations of $20.16 million.

Wall Street Analysts Forecast Growth

XTNT has been the topic of several research reports. BTIG Research restated a “buy” rating and set a $1.00 price objective on shares of Xtant Medical in a research report on Wednesday, May 13th. Craig Hallum reissued a “buy” rating on shares of Xtant Medical in a research note on Wednesday, March 18th. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $1.00.

Hedge Funds Weigh In On Xtant Medical

Hedge funds and other institutional investors have recently modified their holdings of the company. Jane Street Group LLC bought a new position in shares of Xtant Medical in the 2nd quarter worth approximately $26,000. Tradition Wealth Management LLC bought a new position in shares of Xtant Medical in the fourth quarter worth about $79,000. Wiregrass Investment Management LLC purchased a new position in shares of Xtant Medical during the 4th quarter valued at about $81,000. Mink Brook Asset Management LLC grew its stake in shares of Xtant Medical by 125.8% during the 2nd quarter. Mink Brook Asset Management LLC now owns 109,466 shares of the medical device company’s stock valued at $81,000 after acquiring an additional 60,997 shares during the period. Finally, Nano Cap New Millennium Growth Fund L P bought a new stake in Xtant Medical during the 4th quarter worth approximately $220,000. 69.33% of the stock is owned by institutional investors.

About Xtant Medical

Xtant Medical, Inc is a medical technology company focused on the development, manufacturing and distribution of bone graft, spine biologics and related implantable medical devices. The company’s product portfolio is designed to address critical needs in spinal fusion, orthopedics and trauma surgery by providing a range of solutions that promote bone growth, structural support and patient recovery.

The company’s offerings include an array of bone graft substitutes – such as demineralized bone matrix putties and fibers – interbody fusion devices, spinal fixation systems and biologic agents.